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Abstract Despite the clinical utility of echocardiography to measure cardiac target organ injury (TOI) there are
scarcities of data about the reference intervals (RIs) and percentiles of left ventricular (LV) mass (LVM)
and derived indexes (LVMI and LVMI2.7), relative wall thickness (LVRWT) and ejection fraction (LVEF)
from population-based studies in children and adolescents. The aim of this study was to generate reference
intervals RIs of LVM and derived indexes (LVMI and LVMI2.7), LVRWT, and LVEF obtained in healthy
children, adolescents, and young adults from a South-American population. Echocardiographic studies
were obtained in 1096 healthy subjects (5–24 years). Age and sex-specific RIs of LVM, LVMI, LVMI2.7,
LVRWT, and LVEF were generated using parametric regression based on fractional polynomials. After
covariate analysis (i.e., adjusting by age, body surface area) specific sex-specific RIs were evidenced as
necessaries. Age and sex-specific 1st, 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, 97.5th, and 99th
percentile and curves were reported and compared with previously reported RIs. RIs showed high
concordance and complementarity with what was previously reported for the population of North-
American children (0–18 years old). In conclusion, in children and adolescents the interpretation of the
LVM, LVMIs, LVRWT, and LVEF RIs requires sex-related RIs. This study provides the largest
Argentinean database concerning RIs and percentile curves of LVM, LVMIs, LVRWT, and LVEF as
markers of cardiac TOI obtained in healthy children and adolescents. These data are valuable in that they
provide RIs values with which data of populations of children, adolescents can be compared.
Keywords (separated by '-') Left ventricular mass - Left ventricular hypertrophy - Echocardiography - Adolescents - Children -
Epidemiology - Pediatrics - Reference values - Percentiles
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Abstract
Despite the clinical utility of echocardiography to measure cardiac target organ injury (TOI) there are scarcities of data about 
the reference intervals (RIs) and percentiles of left ventricular (LV) mass (LVM) and derived indexes (LVMI and  LVMI2.7), 
relative wall thickness (LVRWT) and ejection fraction (LVEF) from population-based studies in children and adolescents. 
The aim of this study was to generate reference intervals RIs of LVM and derived indexes (LVMI and  LVMI2.7), LVRWT, 
and LVEF obtained in healthy children, adolescents, and young adults from a South-American population. Echocardiographic 
studies were obtained in 1096 healthy subjects (5–24 years). Age and sex-specific RIs of LVM, LVMI,  LVMI2.7, LVRWT, and 
LVEF were generated using parametric regression based on fractional polynomials. After covariate analysis (i.e., adjusting 
by age, body surface area) specific sex-specific RIs were evidenced as necessaries. Age and sex-specific 1st, 2.5th, 5th, 10th, 
25th, 50th, 75th, 90th, 95th, 97.5th, and 99th percentile and curves were reported and compared with previously reported RIs. 
RIs showed high concordance and complementarity with what was previously reported for the population of North-American 
children (0–18 years old). In conclusion, in children and adolescents the interpretation of the LVM, LVMIs, LVRWT, and 
LVEF RIs requires sex-related RIs. This study provides the largest Argentinean database concerning RIs and percentile 
curves of LVM, LVMIs, LVRWT, and LVEF as markers of cardiac TOI obtained in healthy children and adolescents. These 
data are valuable in that they provide RIs values with which data of populations of children, adolescents can be compared.
Keywords Left ventricular mass · Left ventricular hypertrophy · Echocardiography · Adolescents · Children · 
Epidemiology · Pediatrics · Reference values · Percentiles
Introduction
Hypertension (HTN) impacts on heart producing early func-
tional or structural changes that can be detected, even in 
children and adolescents [1]. Left ventricular hypertrophy 
(LVH) is defined as an increase in left ventricular mass 
(LVM) in response to a disease state, due to an increase 
in left ventricular (LV) wall thickness and/or in cavity size 
[2]. The first epidemiological studies that document the 
relationship between the risk of cardiovascular disease and 
LVH were based on its electrocardiographic detection [3]. 
In pediatric HTN, the electrocardiography (ECG) adds lit-
tle information to early diagnosis of target organ injury or 
damage (TOI) [1, 4–7]. LVM can be estimated non-inva-
sively using a several techniques. They include M-mode, two 
(2DE) and three dimensional echocardiography and mag-
netic resonance imaging; all of them are associated with its 
own strengths and weaknesses [2, 9]. The Recommendations 
for Quantification Methods During the Performance of a 
Pediatric Echocardiogram standardize measurements of the 
LV but offer little guidance on how to interpret measure-
ments and there is no mention of LVH in the report [10]. 
However, recently the New Clinical Practice Guideline for 
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the Management of High Blood Pressure in Children and 
Adolescents consider the best-studied and recommended 
echocardiographic measures of LV TOI are: LVM, LV 
relative wall thickness (LVRWT) and LV ejection fraction 
(LVEF) [7].
Ethnic-based differences in LV size and function are 
widely studied in adults [11, 12] but little is known in chil-
dren and adolescents. Despite the clinical utility of echocar-
diographic derived TOI markers there are scarcities of data 
in the Southern Cone of Latin America about the reference 
intervals (RIs) and percentiles of LVM, LVRWT and LVEF 
from prospective population-based studies in healthy chil-
dren and adolescents. Considering that in pediatric clinical 
practice, is absolutely essential normalize the LVM consid-
ering the body surface area (BSA) and/or the body height, 
RIs and percentiles curves were obtained by non-normalized 
and normalized LVM indexes [13–15].
In this context, our research main purpose was to gen-
erate RIs and percentile curves of LVM, LVRWT, and 
LVEF obtained from 2DE and M-mode echocardiography 
in a cohort of children, adolescents and young adults non-
exposed to cardiovascular risk factors (CRFs) from a healthy 
South-American population.
Methods
This study is part of population-based study in Tandil, 
Argentina. Preliminary data and particularly RIs for cardio-
vascular variables have recently been published [16–18]. 
This study was approval by the Institutional Ethics Com-
mittee and written informed consent was obtained.
Asymptomatic and healthy subjects (5–24 years old) from 
the community were considered for enrolment. The upper 
limit of the analyzed population of subjects was set up to 
24 years old to ensure that body growth and development 
were completed and that adulthood was undoubtedly reached 
[19, 20]. In each subject a clinical interview, cardiovascular 
examination, anthropometric assessment and blood sampling 
evaluation were performed. Normotensive [1, 21] subjects 
were included and none had history of hyperlipidaemia, dia-
betes [1, 21, 22], cardiovascular, renal or pulmonary disease. 
Inclusion and exclusion criteria are detailed in supplemen-
tary material. After applying the inclusion and exclusion 
criteria, 1095 subjects were included (Table 1).
Echocardiographic Measurements
Echocardiographic measurements were performed according 
to the Recommendations for Cardiac Chamber Quantifica-
tion [10, 23] and performed by a single researcher using an 
Esaote MyLab 40 ultrasound system (Esaote, Genoa, Italy). 
Echocardiographic methods are detailed in the supplementary 
material.
Using the leading edge-to-leading edge technique, the 
LV end-diastolic and end-systolic dimension (LVEDD and 
LVESD, respectively), inter-ventricular septum thickness 
(IVSD and IVSS, respectively), and posterior wall thickness 
(PWD and PWS, respectively) were measured from 2DE 
images [10, 23]. LVEDD, IVSD, and PWD obtained from the 
2D-guided M-mode images were used to calculate LVM by 
an anatomically validated formula [10, 23, 24].
As can be seen in Figure S1 and Table S1 (supplementary 
material), all the measured parameters showed high intra-
observer repeatability.
Left Ventricular Function
LV end-diastolic and end-systolic volumes (LVEDV and 
LVESV, respectively) were measured from 2DE images, using 
the biplane method of disks’ summation (modified Simpson’s 
Rule). LVEF was then calculated from the respective 2DE-
derived volumes with the following formula:
where SV (stroke volume) is LVEDV-LVESV. LV endocar-
dial and midwall shortening fraction (LVeSF and LVmSF, 





LVM was calculated using a linear method from 2D-guided 
M-mode images:
• 
Additionally, LVM indexes were derived by dividing LVM 
with BSA (LVMI; g/m2) and body height to the allometric 
power of 2.7  (LVMI2.7; g/m2.7) [13–15].
Relative LV Wall Thickness
End-diastolic LVRWT was calculated from 2DE images as 
[23]:
(1)LVEF = ((SV)∕LVEDV) × 100,
(2)




(LVEDD + PWD∕2 + IVSD∕2)
−(LVESD + IVSS∕2 + IVSS∕2)
]/
(LVEDD + PWD∕2 + IVSD∕2) × 100;
(4)





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A step-wise data analysis was done as is described following:
First, we evaluate if LVM, LVM-derived indexes, 
LVRWT, and LVEF RIs for males and females were nec-
essary. Then, sex influence was examined before and after 
adjustment for co-factors, previously identified through sim-
ple bivariate and point-biserial correlations (Table 2), apply-
ing covariance analysis (ANCOVA) (Table 3). ANCOVA 
allows to compare each variable (i.e., LVM) in two or more 
groups (i.e., males vs. females) considering the variability 
of other covariates. Always, prior to the ANCOVA, Lev-
ene’s test for equality of variances and Homogeneity of 
regression slopes’ test were performed. If the Levene test 
is statistical significant (P < 0.05) then the variances in the 
groups are different (i.e., male and female groups are not 
homogeneous), and therefore the assumptions for ANCOVA 
are not met. Additionally, the interpretation of ANCOVA 
and the associated adjusted (marginal) means relies on the 
assumption of homogeneous regression slopes for the com-
pared groups; if this assumption is not met (P < 0.05) the 
ANCOVA results are unreliable. After statistical analysis, 
as a result, generation of sex-specific RIs of LVM, LVM-
derived indexes, LVRWT, and LVEF for males and females 
were considered as necessaries.
Second the mean value and standard deviation (SD) age-
related equations (for males and females) were obtained for 
LVM, LVM-derived indexes, LVRWT and LVEF. With this 
purpose, parametric regression methods based on fractional 
polynomials (FPs) [25], previously used to generate RIs for 
arterial parameters in our Argentinean population [17, 18] 
and the European Arterial Stiffness Collaboration Group 
methodological strategy [26] were implemented (MedCalc 
Software, Ostend, Belgium). Briefly, fitting FPs for age-
specific LVM, LVM-derived indexes, LVRWT, and LVEF 
mean value and SD regression curves were defined using 
iterative procedure (generalized least squares). The obtained 
results enabled to estimate age-specific mean and SD for 
the selected parameters. For instance, LVM mean equation 
could be: = a + b ∗ agep + c ∗ ageq +… , where a, b, c,… 
are the coefficients, and p, q, … are the powers, with num-
bers selected from the set [–1–3, –1, − 0.5, 0, 0.5, 1, 2, 3] 
estimated from the regression for the mean LVM curve, and 
likewise from the regression for the SD curve. Continuing 
the example, FPs with powers [1, 2], that is, with p = 1 and 
q = 2, illustrate an equation with the form a +  b age + c  * 
 age2 [25]. Residuals were used to assess the model fit, which 
was deemed appropriate if the scores were normally distrib-
uted, with a mean of 0 and a SD of 1, randomly scattered 
above and below 0 when plotted against age. The best fitted 
curves, considering visual and mathematical criteria (Kur-
tosis and Skewness) were selected. Then, using the equa-
tions obtained, age-specific percentiles were defined using 
Table 2  Bivariate association between demographic, anthropometric, 
hemodynamic, and blood characteristics and left ventricular param-
eters of children and adolescents (n = 1095)
BSA body surface area, BMI body mass index, SBP, DBP, PP and 
MBP systolic, diastolic, pulse and mean blood pressure, respectively, 
LVRWT left ventricle end-diastolic radius-wall thickness ratio, LV left 




 R 0.205 0.403 0.243 0.129 − 0.064
 p 0.000 0.000 0.000 0.000 0.040
Sex (1: Female, 0: Male)
 R − 0.020 − 0.521 − 0.479 − 0.351 − 0.067
 p 0.519 0.000 0.000 0.000 0.032
Body weight (Kg.)
 R 0.185 0.762 0.428 0.380 -0.018
 p 0.000 0.000 0.000 0.000 0.561
Body height (cm)
 R 0.161 0.726 0.442 0.123 0.021
 p 0.000 0.000 0.000 0.000 0.504
BSA  (m2)
 R 0.186 0.793 0.459 0.309 − 0.003
 p 0.000 0.000 0.000 0.000 0.930
BMI (Kg./m2)
 R 0.149 0.511 0.266 0.477 − 0.032
 p 0.000 0.000 0.000 0.000 0.314
SBP (mmHg)
 R 0.173 0.468 0.329 0.292 0.037
 p 0.000 0.000 0.000 0.000 0.236
DBP (mmHg)
 R 0.104 0.041 − 0.036 − 0.006 − 0.099
 p 0.001 0.186 0.254 0.845 0.002
PP (mmHg)
 R 0.105 0.473 0.384 0.321 0.119
 p 0.001 0.000 0.000 0.000 0.000
MBP (mmHg)
 R 0.153 0.248 0.129 0.132 − 0.051
 p 0.000 0.000 0.000 0.000 0.102
Heart rate (beats/min)
 R 0.172 − 0.289 − 0.283 − 0.199 − 0.025
 p 0.000 0.000 0.000 0.000 0.427
Hematocrit (%)
 R 0.007 − 0.018 − 0.036 − 0.046 − 0.065
 p 0.827 0.573 0.248 0.145 0.037
Glicaemia (mg/dl)
 R 0.033 − 0.008 0.030 0.046 0.006
 p 0.285 0.805 0.330 0.141 0.850
Creatinine (mg/dl)
 R − 0.048 0.006 0.019 − 0.004 0.013
 p 0.127 0.838 0.543 0.892 0.668
Total cholesterol (mg/dl)
 R 0.034 0.090 0.073 0.041 − 0.007
 p 0.279 0.004 0.020 0.187 0.813
Triglicerides (mg/dl)
 R 0.025 − 0.036 − 0.028 − 0.008 − 0.028
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the standard normal distribution (Z) (Table 4). Age-specific 
1th, 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, 97.5th and 
99th percentile curves were calculated as (for instance) mean 
LVM + Zp * SD, where Zp assumed the values of − 2.3263, 
− 1.9599, − 1.6448, − 1.2815, − 0.6755, 0, 0.6755, 1.2815, 
1.6448, 1.9599, and 2.3263, respectively.
The minimum required sample size for RIs construction 
was 377 subjects [27]. As in previous works and according 
to the central limit theorem, a normal distribution was con-
sidered (considering the Kurtosis and Skewness coefficients 
distribution and sample size >30) [28].
Data analysis was done using MedCalc-Statistical Soft-
ware (version/14.8.1., MedCalc Inc., Ostend, Belgium) and 
IBM-SPSS Software (SPSS Inc., Illinois, USA). A p < 0.05 
was considered statistically significant.
Results
General Characteristics of the Analyzed Population
In this research a cohort of 1095 healthy children and ado-
lescents (683 males, 412 females) was analyzed (Table 1).
Reference intervals: discriminant analysis by sex
Table 2 shows demographic, anthropometric, blood and 
hemodynamic variables potentially associated with values of 
LVM, LVMIs, LVEF, and LVRWT. This allowed to individ-
ualize co-factors to be included in the ANCOVA. There was 
a significant positive association between LVM and LVMIs 
(LVMI,  LVMI2.7) and age, male gender, body weight, body 
height, BSA, and BMI (Table 2).
Table  3 show the sex-related analysis of covariance 
(ANCOVA) adjusting by age, BSA, total cholesterol, and/
or hematocrit, destined to determine if the sex discrimina-
tion would be necessary in the RIs of LVM, LVMI,  LVMI2.7, 
LVRWT, and LVEF generation. Although it is important to 
know that associations were found between LVM or LVMI 
and BP and/or heart rate levels, these variables were not used 
as co-factors in the ANCOVA, since the differences in these 
variables between boys and girls of similar age are a physi-
ological aspect that should not be “eliminated” statistically 
(they should not be considered as “confusing” variables).
Although the adjusted mean values of LVRWT were 
similar in males and females, the sex-related differences in 
the variance values (Levene’s test p = 0.009) and age-related 
slopes (Heterogeneity of slopes’ test at the limit of the sig-
nificance, p = 0.065) indicate that sex-related RIs are neces-
sary in order to carry out a robust, accurate, and meticulous 
statistical analysis (Table 3). The analysis of LVM, LVMI, 
 LVMI2.7 and LVEF shows that, after adjusting for covariates, 
males and females presented differences in their mean values 
(p  < 0.05). Consequently, for each of these variables, RIs is 
necessary according to sex. Furthermore, in the case of LVM 
and LVMI the results show sex differences not only the mean 
values but also show differences in the variance (Levene´s 
Test) and in the changes with age (slope of the relation-
ship LVM and LVMI vs. age; Heterogeneity of slopes’ test) 
reinforcing the need to report sex-related RIs. In summary, 
according to results derived from data shown in Tables 2 and 
3, we opted to do sex-related RIs for all included variables: 
LVM, LVMI, LVEF, and LVRWT.
Equations of Mean Value and Standard Deviation 
According to Age for LVM, LVMIs, LVRWT, and LVEF: 
Basis for the Calculation of Individual z‑Scores
After applying the described methodology (fractional poly-
nomials), equations were obtained (see supplementary mate-
rial). Using these equations, it is possible to quantify the 
mean value and SD expected for a certain age, and con-
sequently quantify the z-score of a child in particular as: 
[z-score = (observed value-expected mean)/SD]. This allows 
any researcher or professional to quantify the z-score for a 
particular child, as a way to evaluate how far it moves away 
(SD units) from the expected value for their own age and 
sex. For example, based on the following equations (see sup-
plementary material):
(1) Log LVMI (g/m2.7) Mean = 1.6892 − 0.3650 
Log(Age) + 0.01179 Age
(2) Log LVMI (g /m2.7)  SD = 0 .2723–0.2993 
Log(Age) + 0.01049 Age
For a 12 year-old girl where the LVMI mean (expected) 
and standard deviation are 27.3 g/m2.7 and 4.7 g/m2.7, the 
z-score of a LVMI of 42.0 g/m2.7 is: 3.8 (z-score or standard 
deviation units).
LVM, LVMI, LVEF, and LVRWT: Age and Sex‑Related 
Reference Intervals
The mean value of LVM was 121.13 ± 37.71 g. LVM percen-
tiles corresponding to 5 year age intervals were generated for 
females and males (Table 4). A similar analysis was done for 
each year of age (bi-monthly information from 5 to 24 years 
old) (Table S2 and Table S3; see supplementary material). 
Figure 1a and b show the LVM-age percentiles for females 
and males, respectively.
ventricle, LVMI left ventricle mass index, LVEF left ventricle ejection 
fraction, R Pearson’s correlation coefficient
A p ˂  0.05 (two tailed) was considered statistical significant
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Table 4  Age-related reference intervals for left ventricular mass (LVM, g), LVM indexes (LVMI, g/m2; LVMI, g/m2.7); left ventricular ejection 
fraction (LVEF, %) and relative wall thickness (RWT) in (a) females (n: 412), (b) males (n: 683)
Age (years) Variable 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
(a) Females (n: 412)
 5 (n: 20) LVM 25.41 26.79 28.04 29.55 32.26 35.56 39.21 42.80 45.11 47.21 49.78
LVMI 37.61 39.38 40.96 42.87 46.26 50.35 54.81 59.14 61.89 64.39 67.42
LVMI2.7 16.76 18.48 20.09 22.13 26.00 31.12 37.24 43.75 48.19 52.40 57.76
LVEF 60.99 62.15 63.18 64.38 66.43 68.79 71.24 73.51 74.91 76.14 77.59
RWT 0.22 0.23 0.23 0.24 0.25 0.26 0.27 0.28 0.29 0.29 0.30
 6 (n: 20) LVM 30.84 32.66 34.31 36.31 39.91 44.36 49.29 54.18 57.35 60.24 63.79
LVMI 38.54 40.49 42.25 44.36 48.14 52.73 57.75 62.66 65.81 68.66 72.14
LVMI2.7 17.30 18.86 20.31 22.12 25.52 29.92 35.07 40.45 44.07 47.46 51.74
LVEF 60.17 61.32 62.33 63.51 65.52 67.85 70.25 72.48 73.85 75.06 76.49
RWT 0.22 0.23 0.23 0.24 0.25 0.26 0.28 0.29 0.30 0.31 0.31
 7 (n: 20) LVM 35.92 38.17 40.21 42.71 47.22 52.82 59.07 65.32 69.37 73.09 77.67
LVMI 39.32 41.42 43.31 45.61 49.71 54.71 60.22 65.63 69.11 72.27 76.13
LVMI2.7 17.68 19.12 20.45 22.10 25.16 29.06 33.56 38.20 41.28 44.15 47.75
LVEF 59.57 60.70 61.68 62.84 64.82 67.10 69.47 71.65 73.00 74.19 75.59
RWT 0.22 0.23 0.24 0.24 0.26 0.27 0.29 0.30 0.31 0.32 0.33
 8 (n: 20) LVM 40.58 43.25 45.68 48.66 54.06 60.80 68.37 75.96 80.91 85.47 91.08
LVMI 39.98 42.21 44.22 46.66 51.03 56.39 62.32 68.16 71.92 75.34 79.54
LVMI2.7 17.96 19.30 20.54 22.07 24.88 28.44 32.50 36.63 39.36 41.89 45.04
LVEF 59.11 60.22 61.19 62.33 64.27 66.51 68.82 70.97 72.29 73.45 74.83
RWT 0.22 0.23 0.24 0.24 0.26 0.27 0.29 0.31 0.32 0.33 0.34
 9 (n: 20) LVM 44.80 47.87 50.67 54.11 60.36 68.20 77.04 85.96 91.78 97.16 103.81
LVMI 40.56 42.89 45.00 47.57 52.17 57.83 64.11 70.32 74.32 77.98 82.46
LVMI2.7 18.14 19.42 20.59 22.04 24.68 27.99 31.75 35.55 38.04 40.34 43.20
LVEF 58.77 59.85 60.80 61.92 63.83 66.02 68.29 70.40 71.69 72.83 74.17
RWT 0.22 0.23 0.24 0.25 0.26 0.28 0.30 0.32 0.33 0.34 0.35
 10 (n: 20) LVM 48.57 52.00 55.15 59.02 66.08 74.95 85.01 95.18 101.86 108.02 115.66
LVMI 41.06 43.48 45.68 48.35 53.15 59.07 65.65 72.17 76.39 80.25 84.98
LVMI2.7 18.24 19.48 20.61 22.00 24.52 27.67 31.24 34.82 37.16 39.32 41.98
LVEF 58.51 59.57 60.51 61.60 63.47 65.62 67.85 69.91 71.17 72.28 73.60
RWT 0.22 0.23 0.24 0.25 0.26 0.28 0.30 0.32 0.33 0.34 0.36
 11 (n: 20) LVM 51.88 55.65 59.12 63.38 71.18 81.02 92.22 103.58 111.05 117.96 126.54
LVMI 41.51 44.00 46.27 49.03 54.00 60.14 66.98 73.77 78.17 82.20 87.14
LVMI2.7 18.29 19.50 20.60 21.95 24.41 27.46 30.91 34.36 36.61 38.68 41.24
LVEF 58.32 59.36 60.28 61.35 63.18 65.29 67.47 69.48 70.72 71.81 73.10
RWT 0.22 0.23 0.24 0.25 0.27 0.29 0.31 0.33 0.34 0.35 0.36
 12 (n: 21) LVM 54.74 58.82 62.57 67.20 75.68 86.40 98.64 111.10 119.30 126.91 136.37
LVMI 41.90 44.46 46.79 49.62 54.74 61.07 68.12 75.15 79.70 83.87 89.00
LVMI2.7 18.29 19.48 20.57 21.91 24.32 27.34 30.72 34.12 36.33 38.36 40.87
LVEF 58.18 59.21 60.11 61.16 62.95 65.01 67.14 69.12 70.32 71.39 72.65
RWT 0.23 0.23 0.24 0.25 0.27 0.29 0.31 0.33 0.34 0.36 0.37
 13 (n: 20) LVM 57.18 61.53 65.54 70.48 79.57 91.09 104.27 117.72 126.60 134.84 145.11
LVMI 42.25 44.87 47.25 50.14 55.38 61.87 69.11 76.33 81.01 85.30 90.58
LVMI2.7 18.24 19.43 20.52 21.85 24.27 27.28 30.66 34.06 36.27 38.30 40.80
LVEF 58.10 59.10 59.98 61.01 62.77 64.79 66.87 68.79 69.97 71.02 72.24
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Table 4  (continued)
Age (years) Variable 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
 14 (n: 21) LVM 59.20 63.79 68.02 73.25 82.87 95.10 109.13 123.46 132.95 141.76 152.75
LVMI 42.57 45.23 47.65 50.60 55.94 62.56 69.95 77.33 82.13 86.52 91.93
LVMI2.7 18.16 19.36 20.46 21.80 24.24 27.28 30.71 34.14 36.39 38.45 41.00
LVEF 58.05 59.03 59.90 60.90 62.62 64.60 66.63 68.51 69.66 70.68 71.88
RWT 0.23 0.24 0.25 0.26 0.27 0.30 0.32 0.34 0.35 0.37 0.38
 15 (n: 20) LVM 60.84 65.63 70.06 75.52 85.61 98.45 113.22 128.34 138.36 147.68 159.31
LVMI 42.85 45.55 48.00 51.00 56.42 63.15 70.68 78.19 83.07 87.55 93.07
LVMI2.7 18.05 19.27 20.38 21.75 24.23 27.34 30.84 34.37 36.67 38.79 41.41
LVEF 58.04 59.00 59.84 60.83 62.51 64.44 66.43 68.26 69.39 70.38 71.55
RWT 0.23 0.24 0.25 0.26 0.28 0.30 0.32 0.34 0.36 0.37 0.38
 16 (n: 21) LVM 62.12 67.08 71.66 77.34 87.82 101.18 116.58 132.38 142.86 152.62 164.80
LVMI 43.10 45.83 48.32 51.35 56.84 63.66 71.29 78.91 83.86 88.41 94.01
LVMI2.7 17.91 19.15 20.29 21.69 24.24 27.44 31.05 34.70 37.09 39.30 42.03
LVEF 58.06 59.00 59.82 60.79 62.43 64.31 66.25 68.04 69.14 70.10 71.24
RWT 0.23 0.24 0.25 0.26 0.28 0.30 0.32 0.35 0.36 0.37 0.39
 17 (n: 21) LVM 63.06 68.16 72.87 78.72 89.52 103.32 119.25 135.62 146.49 156.62 169.28
LVMI 43.33 46.08 48.59 51.66 57.20 64.09 71.80 79.51 84.52 89.12 94.79
LVMI2.7 17.75 19.03 20.19 21.63 24.26 27.57 31.34 35.15 37.65 39.96 42.84
LVEF 58.10 59.02 59.83 60.77 62.37 64.21 66.10 67.85 68.91 69.85 70.96
RWT 0.23 0.24 0.25 0.26 0.28 0.30 0.33 0.35 0.36 0.38 0.39
 18 (n: 20) LVM 63.69 68.90 73.72 79.69 90.75 104.91 121.26 138.10 149.29 159.73 172.79
LVMI 43.53 46.31 48.84 51.92 57.51 64.45 72.22 79.99 85.05 89.69 95.41
LVMI2.7 17.57 18.88 20.09 21.57 24.30 27.75 31.68 35.69 38.33 40.77 43.82
LVEF 58.17 59.07 59.86 60.78 62.34 64.13 65.98 67.67 68.71 69.63 70.70
RWT 0.24 0.25 0.25 0.27 0.28 0.30 0.33 0.35 0.36 0.38 0.39
 19 (n: 20) LVM 64.03 69.32 74.22 80.29 91.55 105.98 122.67 139.87 151.32 162.01 175.39
LVMI 43.72 46.51 49.05 52.15 57.77 64.75 72.56 80.38 85.46 90.13 95.88
LVMI2.7 17.38 18.73 19.97 21.51 24.35 27.95 32.09 36.32 39.12 41.72 44.97
LVEF 58.26 59.14 59.91 60.80 62.33 64.07 65.87 67.52 68.53 69.42 70.47
RWT 0.24 0.25 0.26 0.27 0.29 0.31 0.33 0.35 0.37 0.38 0.40
 20 (n: 21) LVM 64.12 69.46 74.41 80.55 91.95 106.57 123.51 140.99 152.63 163.50 177.12
LVMI 43.89 46.68 49.23 52.35 57.98 64.99 72.83 80.68 85.78 90.46 96.23
LVMI2.7 17.17 18.56 19.85 21.45 24.41 28.19 32.56 37.05 40.03 42.81 46.29
LVEF 58.37 59.23 59.97 60.85 62.33 64.03 65.78 67.38 68.37 69.23 70.25
RWT 0.24 0.25 0.26 0.27 0.29 0.31 0.33 0.35 0.37 0.38 0.40
 21 (n: 20) LVM 63.97 69.34 74.32 80.50 91.99 106.73 123.83 141.49 153.27 164.27 178.06
LVMI 44.03 46.84 49.40 52.51 58.16 65.18 73.04 80.89 86.00 90.69 96.47
LVMI2.7 16.95 18.39 19.73 21.39 24.48 28.46 33.07 37.85 41.04 44.03 47.77
LVEF 58.49 59.33 60.06 60.91 62.36 64.01 65.70 67.26 68.22 69.05 70.04
RWT 0.24 0.25 0.26 0.27 0.29 0.31 0.33 0.36 0.37 0.38 0.40
 22 (n: 20) LVM 63.61 68.98 73.97 80.17 91.69 106.49 123.67 141.44 153.30 164.38 178.27
LVMI 44.17 46.98 49.53 52.65 58.30 65.32 73.18 81.03 86.13 90.82 96.59
LVMI2.7 16.72 18.21 19.60 21.33 24.56 28.75 33.64 38.74 42.17 45.38 49.42
LVEF 58.64 59.45 60.16 60.99 62.39 64.00 65.64 67.16 68.08 68.89 69.85
RWT 0.25 0.26 0.26 0.27 0.29 0.31 0.34 0.36 0.37 0.38 0.40
 23 (n: 20) LVM 63.05 68.42 73.39 79.58 91.09 105.89 123.09 140.88 152.76 163.87 177.81
LVMI 44.29 47.10 49.65 52.77 58.41 65.42 73.26 81.10 86.19 90.87 96.62
LVMI2.7 16.48 18.02 19.46 21.26 24.65 29.06 34.26 39.72 43.39 46.86 51.24
LVEF 58.79 59.58 60.27 61.08 62.44 64.00 65.60 67.07 67.96 68.75 69.67
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Table 4  (continued)
Age (years) Variable 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
 24 (n: 21) LVM 62.33 67.66 72.61 78.77 90.22 104.96 122.11 139.87 151.72 162.82 176.75
LVMI 44.40 47.20 49.75 52.86 58.49 65.48 73.30 81.10 86.17 90.83 96.56
LVMI2.7 16.24 17.83 19.32 21.20 24.75 29.40 34.93 40.77 44.73 48.48 53.23
LVEF 58.96 59.73 60.40 61.18 62.51 64.02 65.56 66.98 67.85 68.61 69.51
RWT 0.25 0.26 0.27 0.28 0.30 0.32 0.34 0.36 0.37 0.39 0.40
(b) Males (n: 683)
 5 (n: 22) LVM 15.91 17.95 19.91 22.43 27.38 34.19 42.69 52.11 58.72 65.13 73.47
LVMI 29.15 31.85 34.38 37.53 43.46 51.18 60.26 69.77 76.18 82.22 89.84
LVMI2.7 18.86 20.55 22.13 24.10 27.78 32.54 38.13 43.95 47.86 51.53 56.15
LVEF 61.18 62.15 62.99 63.98 65.67 67.60 69.58 71.41 72.54 73.52 74.69
RWT 0.20 0.21 0.22 0.23 0.25 0.27 0.29 0.32 0.33 0.34 0.36
 6 (n: 22) LVM 22.03 24.60 27.06 30.19 36.26 44.46 54.51 65.46 73.05 80.34 89.73
LVMI 32.76 35.53 38.09 41.28 47.20 54.80 63.62 72.75 78.83 84.52 91.65
LVMI2.7 19.25 20.82 22.28 24.08 27.41 31.67 36.59 41.66 45.02 48.16 52.09
LVEF 60.37 61.39 62.29 63.33 65.12 67.17 69.29 71.25 72.44 73.50 74.75
RWT 0.21 0.22 0.22 0.23 0.25 0.27 0.30 0.32 0.34 0.35 0.37
 7 (n: 24) LVM 28.60 31.71 34.64 38.36 45.48 54.98 66.47 78.80 87.27 95.34 105.68
LVMI 36.00 38.81 41.40 44.61 50.51 58.02 66.65 75.48 81.32 86.76 93.53
LVMI2.7 19.60 21.08 22.44 24.12 27.21 31.12 35.59 40.14 43.15 45.94 49.41
LVEF 59.76 60.82 61.75 62.83 64.69 66.82 69.02 71.06 72.31 73.41 74.71
RWT 0.21 0.22 0.23 0.24 0.26 0.28 0.30 0.33 0.34 0.35 0.37
 8 (n: 23) LVM 35.45 39.06 42.45 46.72 54.83 65.55 78.35 91.95 101.22 110.00 121.18
LVMI 38.90 41.75 44.37 47.59 53.50 60.94 69.43 78.04 83.71 88.96 95.48
LVMI2.7 19.89 21.31 22.61 24.21 27.12 30.79 34.95 39.16 41.93 44.48 47.65
LVEF 59.30 60.38 61.33 62.44 64.33 66.51 68.76 70.85 72.13 73.26 74.60
RWT 0.21 0.22 0.23 0.24 0.26 0.28 0.31 0.33 0.34 0.36 0.37
 9 (n: 24) LVM 42.40 46.48 50.30 55.10 64.14 75.98 90.01 104.78 114.77 124.21 136.16
LVMI 41.51 44.40 47.04 50.28 56.20 63.61 72.01 80.48 86.02 91.14 97.48
LVMI2.7 20.16 21.54 22.79 24.33 27.13 30.63 34.58 38.56 41.16 43.56 46.53
LVEF 58.95 60.04 61.00 62.12 64.03 66.24 68.52 70.63 71.93 73.08 74.43
RWT 0.22 0.23 0.24 0.25 0.26 0.29 0.31 0.33 0.35 0.36 0.37
 10 (n: 23) LVM 49.30 53.83 58.06 63.35 73.27 86.16 101.32 117.17 127.85 137.89 150.56
LVMI 43.85 46.78 49.45 52.72 58.66 66.07 74.42 82.81 88.28 93.32 99.54
LVMI2.7 20.41 21.75 22.98 24.48 27.20 30.60 34.42 38.25 40.75 43.05 45.88
LVEF 58.68 59.78 60.74 61.86 63.78 66.00 68.29 70.41 71.71 72.86 74.22
RWT 0.22 0.23 0.24 0.25 0.27 0.29 0.31 0.33 0.35 0.36 0.38
 11 (n: 25) LVM 56.04 60.99 65.60 71.35 82.09 95.96 112.18 129.06 140.37 150.98 164.33
LVMI 45.96 48.92 51.63 54.93 60.91 68.35 76.70 85.06 90.50 95.50 101.66
LVMI2.7 20.63 21.96 23.17 24.65 27.34 30.67 34.42 38.17 40.61 42.85 45.61
LVEF 58.48 59.58 60.53 61.65 63.57 65.78 68.06 70.17 71.47 72.62 73.98
RWT 0.23 0.24 0.24 0.25 0.27 0.29 0.31 0.34 0.35 0.36 0.38
 12 (n: 27) LVM 62.51 67.86 72.83 79.01 90.51 105.32 122.54 140.38 152.30 163.45 177.44
LVMI 47.84 50.85 53.59 56.94 62.98 70.48 78.88 87.25 92.70 97.69 103.84
LVMI2.7 20.83 22.16 23.37 24.85 27.52 30.84 34.56 38.27 40.69 42.91 45.64
LVEF 58.34 59.43 60.37 61.49 63.39 65.57 67.84 69.94 71.22 72.36 73.70
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Table 4  (continued)
Age (years) Variable 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
 13 (n: 32) LVM 68.63 74.36 79.66 86.25 98.48 114.16 132.33 151.09 163.59 175.26 189.89
LVMI 49.52 52.59 55.37 58.76 64.89 72.48 80.95 89.40 94.87 99.90 106.07
LVMI2.7 21.02 22.36 23.57 25.06 27.74 31.07 34.81 38.54 40.96 43.19 45.93
LVEF 58.25 59.32 60.25 61.35 63.23 65.39 67.62 69.69 70.96 72.08 73.41
RWT 0.23 0.24 0.25 0.26 0.28 0.30 0.32 0.34 0.35 0.36 0.38
 14 (n: 36) LVM 74.34 80.42 86.04 93.02 105.93 122.44 141.53 161.17 174.23 186.42 201.66
LVMI 51.02 54.14 56.97 60.42 66.65 74.36 82.95 91.50 97.04 102.12 108.36
LVMI2.7 21.20 22.55 23.78 25.28 28.00 31.38 35.16 38.94 41.40 43.65 46.43
LVEF 58.19 59.25 60.17 61.25 63.10 65.22 67.41 69.45 70.69 71.79 73.09
RWT 0.24 0.25 0.25 0.26 0.28 0.30 0.32 0.34 0.35 0.36 0.38
 15 (n: 54) LVM 79.61 86.01 91.93 99.27 112.83 130.14 150.10 170.60 184.21 196.89 212.74
LVMI 52.35 55.53 58.42 61.94 68.28 76.13 84.87 93.57 99.20 104.36 110.70
LVMI2.7 21.37 22.74 23.99 25.52 28.29 31.74 35.60 39.46 41.98 44.29 47.14
LVEF 58.17 59.21 60.11 61.17 62.98 65.06 67.21 69.20 70.42 71.49 72.76
RWT 0.24 0.25 0.26 0.26 0.28 0.30 0.32 0.34 0.35 0.36 0.38
 16 (n: 60) LVM 84.38 91.10 97.30 104.98 119.16 137.22 158.03 179.37 193.52 206.70 223.15
LVMI 53.52 56.77 59.72 63.31 69.79 77.80 86.73 95.61 101.37 106.63 113.11
LVMI2.7 21.53 22.93 24.21 25.78 28.61 32.15 36.12 40.10 42.69 45.08 48.02
LVEF 58.18 59.19 60.08 61.11 62.88 64.91 67.01 68.94 70.13 71.18 72.42
RWT 0.24 0.25 0.26 0.27 0.28 0.30 0.32 0.34 0.35 0.36 0.38
 17 (n: 56) LVM 88.66 95.67 102.13 110.13 124.89 143.69 165.32 187.48 202.17 215.83 232.88
LVMI 54.54 57.87 60.88 64.56 71.19 79.39 88.54 97.64 103.53 108.93 115.57
LVMI2.7 21.67 23.11 24.43 26.04 28.96 32.61 36.72 40.84 43.54 46.01 49.07
LVEF 58.22 59.20 60.06 61.07 62.79 64.77 66.81 68.69 69.84 70.86 72.06
RWT 0.24 0.25 0.26 0.27 0.28 0.30 0.32 0.34 0.35 0.36 0.38
 18 (n: 50) LVM 92.42 99.70 106.42 114.72 130.04 149.54 171.97 194.93 210.15 224.30 241.96
LVMI 55.43 58.83 61.93 65.69 72.49 80.91 90.29 99.64 105.70 111.26 118.09
LVMI2.7 21.82 23.30 24.65 26.31 29.34 33.12 37.39 41.69 44.49 47.08 50.28
LVEF 58.27 59.23 60.07 61.05 62.72 64.64 66.61 68.43 69.55 70.53 71.69
RWT 0.25 0.26 0.26 0.27 0.29 0.30 0.32 0.34 0.35 0.36 0.37
 19 (n: 38) LVM 95.67 103.20 110.15 118.75 134.60 154.77 177.98 201.74 217.47 232.12 250.38
LVMI 56.20 59.68 62.85 66.72 73.70 82.35 92.01 101.64 107.89 113.62 120.66
LVMI2.7 21.95 23.48 24.88 26.60 29.74 33.67 38.13 42.62 45.57 48.29 51.65
LVEF 58.35 59.28 60.09 61.04 62.66 64.51 66.42 68.18 69.25 70.20 71.32
RWT 0.25 0.26 0.27 0.27 0.29 0.31 0.32 0.34 0.35 0.36 0.37
 20 (n: 40) LVM 98.42 106.18 113.35 122.22 138.58 159.40 183.36 207.90 224.16 239.29 258.17
LVMI 56.84 60.42 63.67 67.64 74.82 83.72 93.68 103.62 110.08 116.01 123.30
LVMI2.7 22.08 23.66 25.11 26.90 30.16 34.26 38.93 43.65 46.75 49.62 53.18
LVEF 58.45 59.35 60.13 61.05 62.61 64.39 66.23 67.92 68.95 69.86 70.94
RWT 0.25 0.26 0.27 0.28 0.29 0.31 0.32 0.34 0.35 0.36 0.37
 21 (n: 37) LVM 100.67 108.65 116.02 125.15 141.99 163.44 188.13 213.45 230.23 245.85 265.35
LVMI 57.38 61.05 64.39 68.47 75.86 85.03 95.32 105.60 112.29 118.44 126.00
LVMI2.7 22.20 23.84 25.35 27.20 30.60 34.90 39.80 44.77 48.05 51.09 54.86
LVEF 58.56 59.43 60.18 61.06 62.56 64.28 66.04 67.66 68.65 69.52 70.55
RWT 0.26 0.26 0.27 0.28 0.29 0.31 0.33 0.34 0.35 0.36 0.37
 22 (n: 29) LVM 102.44 110.63 118.19 127.55 144.85 166.90 192.32 218.40 235.69 251.80 271.92
LVMI 57.82 61.58 65.02 69.21 76.82 86.29 96.92 107.58 114.52 120.90 128.77
LVMI2.7 22.32 24.02 25.58 27.52 31.07 35.57 40.73 45.98 49.46 52.68 56.69
LVEF 58.69 59.52 60.25 61.09 62.53 64.17 65.85 67.40 68.34 69.17 70.15
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When LVM was indexed according BSA and  height2.7 
the values were 72.44 ± 14.57 g/m2 and 31.09 ± 6.34 g/m2.7. 
Even corrected by BSA and height males presented higher 
values of LVMI and  LVMI2.7 (32.81 ± 6.17 and 28.24 ± 5.54, 
respectively) (Table 1). Age-specific (5 year RIs) percentile 
analyses for LVMI corresponding to males and females are 
shown in Table 4. Similarly, in the supplementary materials, 
Tables S4 and S5 show the RIs for LVMI, defined for each 
year of age. Figure 2a and b show the LVMI-age percentiles 
for females and males, respectively.
Age-specific (5 year intervals, RIs) percentile analyses for 
 LVMI2.7 corresponding to males and females are shown in 
Table 4. In the supplementary materials, Tables S6 and S7 
show the RIs for  LVMI2.7, defined for each year of age. Fig-
ure 3a and b show the  LVMI2.7-age percentiles for females 
and males, respectively.
Table 4  (continued)
Age (years) Variable 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
 23 (n: 30) LVM 103.76 112.13 119.87 129.45 147.18 169.81 195.93 222.76 240.57 257.17 277.92
LVMI 58.17 62.03 65.55 69.87 77.71 87.49 98.50 109.55 116.76 123.40 131.60
LVMI2.7 22.43 24.20 25.82 27.84 31.55 36.28 41.72 47.29 50.97 54.40 58.69
LVEF 58.84 59.63 60.32 61.13 62.50 64.06 65.67 67.14 68.04 68.82 69.75
RWT 0.26 0.27 0.27 0.28 0.29 0.31 0.33 0.34 0.35 0.36 0.37
 24 (n: 31) LVM 104.64 113.18 121.08 130.88 149.01 172.20 198.99 226.56 244.88 261.98 283.35
LVMI 58.42 62.39 66.01 70.45 78.54 88.64 100.05 111.53 119.03 125.94 134.49
LVMI2.7 22.54 24.37 26.07 28.17 32.06 37.03 42.77 48.68 52.60 56.26 60.84
LVEF 59.00 59.75 60.41 61.18 62.48 63.96 65.48 66.88 67.73 68.47 69.35
RWT 0.26 0.27 0.28 0.28 0.30 0.31 0.33 0.34 0.35 0.36 0.37
Fig. 1  Age-specific percentiles 
of left ventricular mass (g) in 

























Journal : Large 246 Article No : 2000 Pages : 19 MS Code : PEDC-D-18-00346 Dispatch : 3-10-2018
Pediatric Cardiology 
1 3
LVEF percentiles corresponding to 5 year age intervals 
were generated for females and males (Table 4). A similar 
analysis was done for each year of age (from 5 to 24 years 
old), as seen in Tables S8 and S9 for females and males, 
respectively (supplementary material). Figure 4a and b 
show the LVEF-age percentiles for females and males, 
respectively.
Finally, LVRWT percentiles corresponding to 5 year age 
intervals were generated (Table 4). A similar analysis was 
done for each year of age (from 5 to 24 years old), as seen 
in Tables S10 and S11 (supplementary material). Figure 5a 
and b show the LVRWT age percentiles for females and 
males, respectively.
Discussion
To our knowledge, this study represent the first South-
American registry concerns the RIs and percentile curves of 
LVM (and derived indexes), LVRWT and LVEF in healthy 
children and adolescents (5–24 years old) obtained from a 
population-based study. From our study the most relevant 
findings are as follows:
First, in children and adolescents, the elaboration of RIs 
for the main recommended parameters for the assessment 
of LV geometry, LV function and TOI requires the consid-
eration of sex-specific tables and percentile curves, since 
in general terms, for equal age, boys have higher levels of 
LVM (grs), LVMI (g/m2), LVMI (gr/m2.7) and LVEF than 
girls (Table 3).
In this regard, although previous studies have clearly 
shown that the levels of LVM, LVMI vary between boys and 
girls [14], there are different publications in which single cut 
points are proposed without considering sex differences [7] 
or studies in which sex has not been considered when ana-
lyzing these parameters as indicators of LVH in children and 
adolescents [29]. There have been numerous studies showing 
the relationship between gender and LVM. These data show 
that females have a lower prevalence of LVH than men for 
any given level of BP [30]. Goble et al. reported that in pre-
adolescent children, LVM is directly related to weight and 
male sex and inversely related to resting heart rate and body 
fat, and suggest that body size, and in particular lean body 
mass, explains much of the variability in cardiac growth 
seen in children [31]. Existing studies show controversial 
results with respect to sex-related differences in LVM cor-
rected by the lean body mass [15, 32]. Considering the lack 
Fig. 2  Age-specific percentiles 
of left ventricular mass index 
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of a definitive answer to the question of whether the rela-
tion between lean body mass and LVM differs by sex, it 
is prudent to use sex-specific RIs. In Argentina, Escudero 
et al. reported in young non-hypertensive subjects that the 
difference in LVM between women and men was partially 
explained (16%) by sex differences in BP, supporting an 
early effect of BP on cardiac mass even in the absence of 
hypertension [33].
Second, the RIs found for the analyzed South-American 
population showed a high similarity and a potential com-
plementarity with those previously reported by Khoury et al. 
in North-American population (2009). Similarity, this char-
acteristic is reflected in the shape of the curves with a sur-
prising overlap in the clinically relevant percentiles (95th) 
for both boys and girls between 5 and 18 years old (Fig. 6). 
Complementarity, given that the Khoury et  al. reports 
RIs for some ages lower than those reported in this study 
(0–5 years), while in the present work we report RIs for ages 
that exceed those reported by Khoury et al. (18–24 years 
old) [14]. As our results show (Table 4; Fig. 6), even having 
reached adulthood (18 years old), the values of LVM con-
tinue to be age-dependent; therefore requiring age-related 
RIs even in young adults. On the other hand, note that 
both the values reported in our study and those reported by 
Khoury et al. [14] differ significantly with that data reported 
by Chinali et al. [29] (Fig. 6). Our data have similarities with 
other studies in terms of mean LVMI [31, 34], and  LVMI2.7 
[14, 15]. However, only the study of Khoury et al. presented 
the LVMI as sex- and age-related percentiles. These data 
surge from a retrospective analysis of the database of the 
Echocardiography Laboratory at Cincinnati Children’s Hos-
pital. Since no available database exists in Latin America 
territory, a comparative analysis with the North-American 
largest database of LVMI and  LVMI2.7 [14] was made. As 
can be seen, LVMI values of the Argentinean population 
are very similar to those observed in North-American chil-
dren and adolescents. Moreover, the age-related changes of 
 LVMI2.7 showed by both populations are very similar.
Third, the use of single cut-off point of LVMI2.7proposed 
by Khoury et al. [14] in girls and boys over 9 years old (40 
and 45 g/m2.7, respectively), would underestimate the diag-
nosis of LVH, given that: (a) those values are closer to our 
99th percentile (Fig. 6), (b) the tendency of the percentile 
levels of LVMI2.7 (75th, 90th, 95th, 99th) to increase gradu-
ally over 10–12 years, evidences that a fixed cut-off point 
would be theoretically inappropriate, generating a pattern 
of age-dependent sub-diagnosis. In fact, the differences 
between the 95th of our population and the proposed single 
Fig. 3  Age-specific percentiles 
of left ventricular mass index 
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cut-off points (40 and 45 g/m2.7) show variations with age 
(Fig. 7). In this way, the age for which greater differences 
are reached (higher sub-estimate of diagnosis of hypertro-
phy) are 12.8 years in girls (difference of 3.74 g/m2.7) and 
11.2 years in boys (difference of 4.39 g/m2.7). The differ-
ences between the 95th percentile and the fixed cut-off point 
after these ages show a gradual decrease, reaching values 
similar at 20 years and 18.4 years for females and males, 
respectively (Fig. 7). Furthermore, if a fixed cut-off point 
is used for the  LVMI2.7 of 51 g/m2.7, as suggested by the 
“Clinical Practice Guideline for Screening and Manage-
ment of High Blood Pressure in Children and Adolescents” 
[7], it leads to important differences (age-dependent) in the 
levels of under diagnosis of LVH (Fig. 7). About this, the 
differences between the 95th percentile in our population 
and a fixed cut-off value of 51 g/m2.7, could reach 14.74 and 
10.39 g/m2.7, for girls and boys, respectively (reaching these 
differences at ages of 12.8 and 11.2 years for girls and boys, 
respectively) (Fig. 7). Additionally, this fixed cut-off point 
would determine that at lower and higher ages than those 
reported above, the levels of underestimation of LVH are 
drastically reduced (Fig. 7). In summary, although a value 
of  LVMI2.7 >51 g/m2.7 clearly represents a probable case 
of LVH, the significant distance between this value and the 
95th percentile, in addition to the age-dependence of these 
differences, highlights the need to have other ways of assess-
ing the LVH.
On the other hand, when analyzing our data according to 
the fixed cut-off points for LVMI (g/m2) proposed by Flynn 
et al. (115 g/m2 for boys, 95 g/m2 for girls) [7], it is again 
evident that the differences vary according to age and sex 
(Table 4). For example, in a teenager with LVMI value in 
the 95th percentile according to age and sex, the difference 
with respect to fixed cut-off point gradually decreases with 
increasing age (in males this difference is 0 when reaching 
just 22.2 years old) (Table 4).
Fourth, our study reports for the first time RIs of the vari-
ables used for the diagnosis and follow-up of cardiac TOI 
obtained in a South American population. In this regard, to 
date there were no reports of RIs for these echocardiographic 
variables in populations of our region. Consequently, physi-
cians had to be guided by RIs obtained from populations of 
other countries with different ethnic composition [14]. In 
addition to body mass index, ethnicity contributes to dif-
ferences in prevalence of LVH. A collaborative study of the 
International Pediatric Hypertension Association found that 
Fig. 4  Age-specific percentiles 
of left ventricular ejection 
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LVH and concentric hypertrophy occurred most frequently 
in hypertensive Hispanic children [35].
The LVRWT allows determining the LV geometry and 
classification of LV mass increase as either concentric 
hypertrophy (LVRWT > 0.42) or eccentric hypertrophy 
(LVRWT ≤ 0.42) [1, 7]. Our data showed that all children 
and adolescents showed normal LV wall thickness. In this 
way the average of IVSD and PWD was 7.37 ± 1.04 mm with 
maximum values of 10 mm. Our values of LVRWT are in 
accordance with previous works [15, 31, 36].
In our study, subjects presented normal LV function 
reflected by normal values of LVEF, SV, CO, and E/A ratio 
(Tables 1, 4, S7 and S8).
Study Limitations
This research used a cross-sectional design; consequently, the 
age-related changes of LVM (and derived indexes), LVRWT, 
and LVEF should be interpreted with caution, since it may 
misestimate the real time-dependent (age-related) change of 
these markers of TOI of the subjects included in the analyzed 
population. Although it is difficult, new longitudinal studies 
are necessary to measure the prognostic impact of cardiac TOI 
as outcome. In our study protocol, we did not include ethnic-
ity as a study variable. It should be noted that this population 
has certain characteristics that may not be fully applicable to 
other races, ethnicities or regions. It can be thought that works 
of this type would only be of interest to a small portion of the 
professionals. However, at present, globalization has modified 
the world population distribution, determining that millions of 
people do not live in their country of origin and/or that of their 
parents (i.e., Europeans living in South-America or vice versa). 
For this reason, it is essential to have information on potential 
particularities (differentials) that could exist in parameters of 
cardiovascular structure/function, in native and non-native 
populations of a given country. In this context, we need works 
that, by means of precise approaches, allow us to know the 
cardiovascular characteristics of people with different origins, 
and very especially to compare populations.
Conclusions
Our data show that in children and adolescents, the inter-
pretation of the LVM (and derived indexes), LVRWT 
and LVEF RIs requires sex and BSA-related RIs. In par-
ticular, the use of single cut-off point of  LVMI2.7 would 
Fig. 5  Age-specific percentiles 
of left ventricular relative wall 
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underestimate the diagnosis of LVH, generating a pattern 
of age-dependent sub-diagnosis.
This study provides the largest south-american database 
concerning RIs and percentile curves of LVM, LVRWT, 
and LVEF as markers of cardiac TOI obtained in healthy 
children and adolescents non-exposed to CRFs.
Our results show the compatibility of the RIs obtained 
from our population with those described in the European 
guidelines. In particular, the RIs found for the analyzed 
South-American population (Argentina) showed a high 
similarity and a potential complementarity with those 
Fig. 6  Age-specific percentiles of left ventricular mass index (LVMI; 
g/m2.7) obtained in our population and those reported from a Euro-
pean [29] and North-American population [14]. 50th, 95th, and 99th 
percentiles obtained in boys and girls (top and bottom panel, respec-
tively) were represented. Line A: cut-off point to consider severe left 
ventricular hypertrophy [34]. Line B: threshold to diagnose left ven-
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reported by Khoury et al. in North-American children and 
adolescents.
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